Immucell CORP /DE/ 8-K filings

ImmuCell Corporation has modified its lease agreement for its Portland facility and updated its corporate by-laws.

ImmuCell Corporation announced a 55% increase in product sales for the second quarter of 2024 compared to the same period last year, alongside updates on production capacity and regulatory hurdles.

ImmuCell reports a significant 55% increase in preliminary, unaudited sales for the second quarter of 2024, driven by increased production and strong demand.

ImmuCell Corporation has amended its lease agreement to revise the payment schedule for tenant improvements, shifting a large lump sum payment to a series of smaller monthly payments and a final payment.

ImmuCell Corporation successfully held its 2024 Annual Meeting, electing all director nominees and ratifying the selection of Wipfli LLP as its independent auditor.

ImmuCell Corporation has provided an update on the regulatory status of its Re-Tain product, indicating a potential launch between the second quarter of 2025 and the first quarter of 2026, pending FDA approvals.

ImmuCell Corporation announced record first-quarter sales of $7.3 million, a 111% increase year-over-year, while also facing a regulatory setback for its Re-Tain product.

ImmuCell Corporation has entered into an agreement to sell up to $11 million of its common stock through an at-the-market offering and amended its loan agreement to remove restrictions on equity issuances.

ImmuCell Corporation reported a record $7.3 million in sales for the first quarter of 2024, a 111% increase compared to the same period last year.

ImmuCell Corporation and Norbrook Laboratories Limited have amended their supply agreement, setting a termination date of November 30, 2024, for their Re-Tain product collaboration.

ImmuCell Corporation has extended its $1 million line of credit with Gorham Savings Bank to September 11, 2025, and obtained a waiver for a key debt service coverage ratio.

ImmuCell's 2023 financial results were impacted by production issues, though the company saw a strong sales increase in the fourth quarter and is making progress with its Re-Tain product.